losartan has been researched along with Peritoneal Diseases in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Peritoneal Diseases: Pathological processes involving the PERITONEUM.
Excerpt | Relevance | Reference |
---|---|---|
"Losartan suppressed the implant surface area of experimental endometriosis in rats and reduced the levels of plasma VEGF, TNF-α, PTX-3 and CRP." | 3.81 | Regression of experimental endometriotic implants in a rat model with the angiotensin II receptor blocker losartan. ( Ates, U; Cakmak, B; Cavusoglu, T; Erbaş, O; Meral, A; Nacar, MC, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cakmak, B | 1 |
Cavusoglu, T | 1 |
Ates, U | 1 |
Meral, A | 1 |
Nacar, MC | 1 |
Erbaş, O | 1 |
1 other study available for losartan and Peritoneal Diseases
Article | Year |
---|---|
Regression of experimental endometriotic implants in a rat model with the angiotensin II receptor blocker losartan.
Topics: Angiotensin Receptor Antagonists; Animals; C-Reactive Protein; Cytokines; Disease Models, Animal; En | 2015 |